Clinical Trial Update: Effects of High-Dose Resveratrol in Non-Diabetic Obese Males [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating high-dose resveratrol in non-diabetic obese males has completed, with obesity and diabetes listed as conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes
• Obesity

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: Khoo Teck Puat Hospital | Conditions: Obesity, Diabetes | Phase 2 | Status: COMPLETED